AbSci Adds Protein Characterization Expert, Alan Herman, PhD to Scientific Advisory Board
“There’s an electricity of discovery here like Genentech and Amgen,” said Dr. Herman. “AbSci’s ability to fold proteins is an innovative art form. This technology enables more efficient manufacturing, which will bring down the price of drugs.”
AbSci Appoints William F. Bennett, PhD to Scientific Advisory Board
“The culture here reminds me of Genentech in the early days. It’s an honor to join the team as a Scientific Advisor,” said Dr. Bennett. “AbSci’s technology is a quantum improvement in bacterial expression systems.”
AbSci at 36th JP Morgan Conference January 8th – 11th.
AbSci at 36th JP Morgan Conference January 8th – 11th. The team is fully booked out for the remainder of JPM – Contact Kole Krieger to schedule a phone call – kkrieger@abscibio.comAbSci Appoints Fred Larimore, PhD to Scientific Advisory Board
AbSci announced today the appointment of Fred Larimore, PhD to AbSci’s Scientific Advisory Board. Dr. Larimore brings over 30 years of experience in biopharmaceutical manufacturing and process development at leading pharmaceutical companies …
2017: A Big Year for AbSci – Growth and Continued Expansion
AbSci, a global leader in breakthrough biomanufacturing technologies, today announced that it is further expanding its offices and laboratory facilities. “We’ve seen a significant increase in partnership deal flow, which is a testament to the innovation and quality of work performed by our scientists,” said CEO and Founder, Sean McClain …